BTAI
Price
$1.85
Change
+$0.16 (+9.47%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
9.19M
18 days until earnings call
SYBX
Price
$1.16
Change
+$0.01 (+0.87%)
Updated
Apr 24, 01:10 PM (EDT)
Capitalization
13.49M
Ad is loading...

BTAI vs SYBX

Header iconBTAI vs SYBX Comparison
Open Charts BTAI vs SYBXBanner chart's image
BioXcel Therapeutics
Price$1.85
Change+$0.16 (+9.47%)
Volume$4.51K
Capitalization9.19M
Synlogic
Price$1.16
Change+$0.01 (+0.87%)
Volume$370
Capitalization13.49M
BTAI vs SYBX Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. SYBX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and SYBX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BTAI: $1.69 vs. SYBX: $1.15)
Brand notoriety: BTAI and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 1% vs. SYBX: 41%
Market capitalization -- BTAI: $9.19M vs. SYBX: $13.49M
BTAI [@Biotechnology] is valued at $9.19M. SYBX’s [@Biotechnology] market capitalization is $13.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileSYBX’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • SYBX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BTAI and SYBX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 5 TA indicator(s) are bullish while SYBX’s TA Score has 5 bullish TA indicator(s).

  • BTAI’s TA Score: 5 bullish, 3 bearish.
  • SYBX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BTAI and SYBX are a good buy in the short-term.

Price Growth

BTAI (@Biotechnology) experienced а -7.14% price change this week, while SYBX (@Biotechnology) price change was +14.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

SYBX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYBX($13.5M) has a higher market cap than BTAI($9.19M). SYBX YTD gains are higher at: -17.600 vs. BTAI (-71.750). SYBX has higher annual earnings (EBITDA): -23.01M vs. BTAI (-56.15M). BTAI has more cash in the bank: 233M vs. SYBX (18.9M). SYBX has less debt than BTAI: SYBX (0) vs BTAI (105M). BTAI has higher revenues than SYBX: BTAI (2.28M) vs SYBX (8K).
BTAISYBXBTAI / SYBX
Capitalization9.19M13.5M68%
EBITDA-56.15M-23.01M244%
Gain YTD-71.750-17.600408%
P/E RatioN/AN/A-
Revenue2.28M8K28,450%
Total Cash233M18.9M1,233%
Total Debt105M0-
FUNDAMENTALS RATINGS
BTAI vs SYBX: Fundamental Ratings
BTAI
SYBX
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9783
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BTAI's Valuation (82) in the Biotechnology industry is in the same range as SYBX (86). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

BTAI's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SYBX (100). This means that BTAI’s stock grew similarly to SYBX’s over the last 12 months.

SYBX's SMR Rating (95) in the Biotechnology industry is in the same range as BTAI (100). This means that SYBX’s stock grew similarly to BTAI’s over the last 12 months.

SYBX's Price Growth Rating (83) in the Biotechnology industry is in the same range as BTAI (97). This means that SYBX’s stock grew similarly to BTAI’s over the last 12 months.

SYBX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as BTAI (100). This means that SYBX’s stock grew similarly to BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAISYBX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAFU1.470.12
+8.89%
Wah Fu Education Group Limited
BITF1.000.06
+6.11%
Bitfarms Ltd
YUMC46.812.03
+4.53%
Yum China Holdings
QS3.980.11
+2.84%
QuantumScape Corp
CMT15.03-0.16
-1.05%
Core Molding Technologies

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with ORMP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
+0.60%
ORMP - BTAI
44%
Loosely correlated
+0.66%
AXON - BTAI
42%
Loosely correlated
+3.82%
INO - BTAI
39%
Loosely correlated
+0.81%
IGMS - BTAI
38%
Loosely correlated
-4.79%
ARRY - BTAI
37%
Loosely correlated
+0.93%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with NEUP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then NEUP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
+3.38%
NEUP - SYBX
64%
Loosely correlated
+1.19%
BTAI - SYBX
37%
Loosely correlated
+0.60%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
+2.01%
ATXS - SYBX
30%
Poorly correlated
+12.55%
More